Arvinas, Inc. (ARVN)
9.36
-0.24
(-2.50%)
USD |
NASDAQ |
Aug 26, 09:55
Arvinas Shareholders Equity (Quarterly) : 562.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 562.20M |
| March 31, 2026 | 386.80M |
| December 31, 2025 | 433.90M |
| September 30, 2025 | 564.40M |
| June 30, 2025 | 609.30M |
| March 31, 2025 | 660.10M |
| December 31, 2024 | 561.70M |
| September 30, 2024 | 586.00M |
| June 30, 2024 | 600.20M |
| March 31, 2024 | 609.70M |
| December 31, 2023 | 660.00M |
| September 30, 2023 | 457.20M |
| June 30, 2023 | 463.60M |
| March 31, 2023 | 511.00M |
| December 31, 2022 | 564.90M |
| September 30, 2022 | 621.50M |
| June 30, 2022 | 670.60M |
| March 31, 2022 | 723.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 781.70M |
| September 30, 2021 | 817.74M |
| June 30, 2021 | 582.95M |
| March 31, 2021 | 615.30M |
| December 31, 2020 | 642.26M |
| September 30, 2020 | 205.12M |
| June 30, 2020 | 197.78M |
| March 31, 2020 | 211.71M |
| December 31, 2019 | 226.69M |
| September 30, 2019 | 134.16M |
| June 30, 2019 | 116.51M |
| March 31, 2019 | 127.74M |
| December 31, 2018 | 136.67M |
| September 30, 2018 | 36.32M |
| June 30, 2018 | 44.28M |
| March 31, 2018 | 51.18M |
| December 31, 2017 | 0.2459M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 310.70M |
| Definium Therapeutics, Inc. | 918.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 675.10M |
| Total Liabilities (Quarterly) | 112.90M |
| Debt to Equity Ratio | 0.0146 |
| Current Ratio | 7.906 |
| Net Debt Paydown Yield | 0.09% |